Hong Kong Institute of Medical Laboratory Sciences Quality Assurance Programme Ltd.
Quality Assurance Programme in Haematology and Serology
Complete Blood Count
| Survey materials: | Two whole blood samples. | 
| Tests requested: | WBC, RBC, Hb, Hct, MCV and Platelet. | 
Coagulation
| Survey materials: | Two lyophilized plasma samples. | 
| Tests requested: | APTT, PT and INR. | 
Blood Film
| Survey materials: | Two slides of peripheral blood film with brief history and CBP results. | 
| Tests requested: | Differential Count, RBC Morphology, WBC Morphology and Platelet Morphology. | 
ABO and Rh(D) Grouping
| Survey materials: | Two sets of blood cells suspension and Serum. | 
| Tests requested: | ABO Grouping and Rh(D) Grouping. | 
Objective Criteria for Performance Evaluation of Haematology and Serology
In each quarterly survey exercise a package of two EDTA-blood, two smears, two lyophilized plasmas and two citrated cell suspensions/sera will be sent to participating laboratories for full blood count, white cell differential/cell morphology, coagulation studies and blood group serology, respectively. Survey data must be returned for statistical analysis before the due date, otherwise regarded as late return. "Late Return" will be stated in the survey report.
Results of blood count and coagulation study generated by participating laboratory will not only be compared to the overall mean derived from all returned results but also compared to the mean established from participants using same instrument and reagent, respectively. A variable of standard deviation beyond "2" suggests a significant deviation. Critical review of the analytical procedure is desirable.
Readouts of white cell differential and cell morphology and haemagglutination scores of ABO- and Rh-grouping of participating laboratory will be compared to the mode value established from all returned results and the consensus value of the Haematology Panel.
Remarks
Should
there be any data discrepancy in the survey report or any disagreement with the
performance evaluation, participant can appeal to the chairman of HKIMLSQAP for
amendment and review.
Confidentiality
HKIMLSQAP is committed to ensure the confidentiality of all participants. The information of participants and proprietary rights of HKIMLSQAP are protected as follows:
a.       Each participant is assigned with a laboratory code. Either the code or the name is used for communication between the participant and HKIMLSQAP.
b.      The key to decipher the identities of participants is limited to few designated personnel (Chairperson, Secretary, Webmail Administrator and Office Staff) of HKIMLSQAP. Details of participants are not released to any persons other than the designated personnel.
c.      All personnel involved in the running of the programme shall sign the letter of undertaking not to disclose the identities of participants. HKIMLSQAP has kept a register of the persons signing Letter of Undertaking.
d.      HKIMLSQAP is forbidden to release the identity of the participant (i.e. the name and confidential code of the laboratory) to any outsiders unless requested by law.
e.      Although accreditation body would access to participant's performance during assessment and information which may be released to accreditation body will be limited to either the name or the code of the participants but not both.
Major Sponsors:
 
  
Contact us:
(852) 2499 0015
[Phone]
(852) 2124 2798 [Fax]
info@hkimlsqap.org [Email]                
The Chairman
Quality Assurance Programme Committee
Hong Kong Institute of Medical Laboratory Sciences Quality Assurance Programme Ltd.
Flat 1711, 17/F, Block C, Bell House,
525 - 543 Nathan Road, Yaumatei, Kowloon, Hong Kong.
Last updated on 10 October 2025.